Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Taxes (2023 - 2025)

Zhengye Biotechnology Holding has reported Current Taxes over the past 3 years, most recently at $330627.6 for Q4 2025.

  • Quarterly Current Taxes rose 14.95% to $330627.6 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $330627.6 through Dec 2025, up 14.95% year-over-year, with the annual reading at $335000.0 for FY2025, 18.37% up from the prior year.
  • Current Taxes was $330627.6 for Q4 2025 at Zhengye Biotechnology Holding, up from $16000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $330627.6 in Q4 2025 and troughed at $16000.0 in Q2 2025.
  • The 3-year median for Current Taxes is $303183.1 (2023), against an average of $238248.5.
  • Year-over-year, Current Taxes dropped 9.77% in 2024 and then increased 14.95% in 2025.
  • A 3-year view of Current Taxes shows it stood at $318746.6 in 2023, then dropped by 9.77% to $287619.7 in 2024, then increased by 14.95% to $330627.6 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Current Taxes are $330627.6 (Q4 2025), $16000.0 (Q2 2025), and $287619.7 (Q4 2024).